Abstract

MANZUR BARBUR, María Carolina et al. State of the art of cardiorenal syndrome, advantages and limitations of known therapies. Rev. colom. nefrol. [online]. 2021, vol.8, n.2, e301.  Epub Jan 01, 2022. ISSN 2500-5006.  https://doi.org/10.22265/acnef.8.2.517.

Interactions between heart and kidney disease have been classified as cardiorenal syndromes. The current classification includes five subtypes, which are: acute heart failure leading to acute kidney failure (type 1), chronic heart failure leading to kidney failure (type 2), acute kidney injury leading to heart failure (type 3), chronic kidney disease leading to heart failure (type 4) and systemic conditions leading to heart and kidney failure (type 5) (table 1)1,2.

In this review, we discuss the definition, classification, pathophysiology, focusing on acute phases treatment and its recovery, exposing the actual evidence for diuretics and ultrafiltration in order to intervene in a timely manner, pointing out the main advantages and limitations of each of the available strategies of treatment in order to reduce the risk of clinical events, re-hospitalization and death.

Keywords : cardiorrenal syndrome; decompensated heart failure; diuretic; diuretic resistance; ultrafiltration; peritoneal dialysis..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )